Navigation Links
Kensey Nash Receives FDA 510(k) Clearance for New Safe-Cross(R) Vessel Wall Detection Technology
Date:2/20/2008

rkets. Many of the products are based on the Company's significant expertise in the design, development, manufacturing and processing of absorbable biomaterials, which has led to partnerships to commercialize technologies. Kensey Nash has also commercialized a series of innovative products through its own direct endovascular sales force. The Company is known as a pioneer in the field of arterial puncture closure, as the inventor and developer of the Angio-Seal(TM) Vascular Closure Device, which is licensed to St. Jude Medical, Inc.

Cautionary Note for Forward-Looking Statements

This press release contains forward-looking statements that reflect the Company's current expectations about its prospects and opportunities. The Company has tried to identify these forward looking statements by using words such as "expect," "anticipate," "estimate," "plan," "will," "forecast," "believe," or similar expressions, but these words are not the exclusive means for identifying such statements. The Company cautions that a number of risks, uncertainties, and other important factors could cause the Company's actual results to differ materially from those in the forward-looking statements including, without limitation, the Company's success in launching its endovascular products into the marketplace, the Company's dependence on three major customers (St. Jude Medical, Arthrex and Orthovita) and their success in selling Kensey Nash related products in the marketplace, the impact of product recalls and other manufacturing issues, and competition from other technologies, among other important risks. For a more detailed discussion of these and other factors, please see the Company's SEC filings, including the disclosure under "Risk Factors" in those filings. Except as expressly required by the federal securities laws, the Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, changed circumstances or future
'/>"/>

SOURCE Kensey Nash Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Kensey Nash to Present at the Canaccord Adams Small-Cap Orthopedics Conference
2. Kensey Nash to Participate in the Sidoti Fifth Annual Palm Beach Emerging Growth Institutional Investor Forum Conference
3. Kensey Nash to Participate in the RBC Capital Markets Healthcare Conference
4. Kensey Nash to Present at the Sidoti Sixth Annual West Coast Emerging Growth Institutional Investor Forum Conference
5. Barr Receives Final Approval for Generic Mirapex(R) Tablets, 0.125mg, 0.25mg, 0.5mg, 1mg & 1.5mg
6. Boehringer Ingelheim Pharmaceuticals, Inc. Receives the NCQA Seal Of Approval
7. Abbott Receives FDA Approval for SIMCOR(R) (Niaspan(R) / simvastatin), a Novel Combination Medicine for Comprehensive Cholesterol Management
8. BioSpace.com Receives WEDDLEs 2008 Users Choice Award for Best Job Boards
9. Sanofi-aventis SoloSTAR(R) Insulin Pen for Lantus and Apidra Receives the Prestigious GOOD DESIGN Award
10. AGA Medical Corporation Receives European CE Mark Approval for the AMPLATZER(R) Duct Occluder II
11. CryoLife Receives FDA 510(k) Clearance for SynerGraft(R) Processed Human Pulmonary Heart Valves
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008)...and Awards Celebration has show of ...ly 25 /- With the life sciences posit...ding an advantage amidst global,competition requir...2BUSINESS 2008 Conference and Awards Celebration, ...t edge., The inaugural event will draw some 100 s...
(Date:7/25/2008)...Xinhua-- Over 300 of,China,s top stem...lobe,shared their latest results and held China,s ...nt stem (iPS) cell research during the just,conclu...orum at the China,Medical City complex in Taizhou,...n Hu, Chairman of Beike Biotechnology Co., Ltd., (...
(Date:7/25/2008)...any,s IPLEX(TM) Program in Myotonic ...ly 25 /- Insmed Inc. (Nasda...opharmaceuticals, today,announced that Geoffrey Al...3th Annual Drug Discovery and Development of Innov...t 9:25 AM ET., Dr. Allan will be participating in...
(Date:7/25/2008)...-FirstCall/ -- Insmed Inc. (Nasdaq:,INSM), a devel..., today,announced that it will host a conference c...s its results for the second quarter 2008. Insmed ...ress release before the market,opens on August 8th...ease dial 866-202-1971,(U.S. callers) or 617-213-8...
Breaking Biology Technology:Conference to Turn Scientists of Color into PA-Based Entrepreneurs Set for November 2Conference to Turn Scientists of Color into PA-Based Entrepreneurs Set for November 3Global Stem Cell Forum in China Showcases Cutting Edge Research, Focuses on New Findings for iPS Cells 2Global Stem Cell Forum in China Showcases Cutting Edge Research, Focuses on New Findings for iPS Cells 3Global Stem Cell Forum in China Showcases Cutting Edge Research, Focuses on New Findings for iPS Cells 4Insmed CEO to Present at Drug Discovery & Development Conference 2Insmed to Host Second Quarter 2008 Conference Call 2
...evel protein expression within a variety,of cell...agene , Recombinant adenoviruses provide a versa...escribe the AdEasy adenoviral vector,system, ... viruses. Constructing a recombinant adenoviral,...ss in which the desired,expression cassette is f...
...r RT-PCR using the Absolutely RNA , ...ter Jeff Braman , Stratagene , S...ation kits are , not satisfactory for rev... tested several commercially available RNA ...ontaminating DNA will produce false positive ampli...
...ful method to detect protein interactions in mamma...Stratagene , With Stratagenes mammalian two-hybr...protein-protein interactions via the activation,...s as a result of,reconstitution of a functional ...,two hybrid proteins. It allows researchers to st...
...ferentiated Adipocytes ,,, A new para...i C. Halvorsen ,Zen-Bio, Inc. , Peter Pingerel... , Ligand Pharmaceuticals , Michael R. Briggs ...ne introduces new tools to facilitate the study of...d Adipocytes and Human Differentiated Adipocytes.,...
Other Biology Technology:Generate Adenovirus Vectors in E. coli by Homologous Recombination,with the AdEasy Adenoviral Vector System 2Generate Adenovirus Vectors in E. coli by Homologous Recombination,with the AdEasy Adenoviral Vector System 3Generate Adenovirus Vectors in E. coli by Homologous Recombination,with the AdEasy Adenoviral Vector System 4Generate Adenovirus Vectors in E. coli by Homologous Recombination,with the AdEasy Adenoviral Vector System 5Generate Adenovirus Vectors in E. coli by Homologous Recombination,with the AdEasy Adenoviral Vector System 6New Kit Generates Exceptionally Pure Total RNA for RT-PCR 2New Kit Generates Exceptionally Pure Total RNA for RT-PCR 3New Kit Generates Exceptionally Pure Total RNA for RT-PCR 4New Kit Generates Exceptionally Pure Total RNA for RT-PCR 5New Mammalian Two-Hybrid System Detects Protein-Protein Interactions 2New Mammalian Two-Hybrid System Detects Protein-Protein Interactions 3New Mammalian Two-Hybrid System Detects Protein-Protein Interactions 4New Mammalian Two-Hybrid System Detects Protein-Protein Interactions 5New Mammalian Two-Hybrid System Detects Protein-Protein Interactions 6New Mammalian Two-Hybrid System Detects Protein-Protein Interactions 7New Mammalian Two-Hybrid System Detects Protein-Protein Interactions 8New Mammalian Two-Hybrid System Detects Protein-Protein Interactions 9Human Primary Preadipocytes and Differentiated Adipocytes 2Human Primary Preadipocytes and Differentiated Adipocytes 3Human Primary Preadipocytes and Differentiated Adipocytes 4Human Primary Preadipocytes and Differentiated Adipocytes 5Human Primary Preadipocytes and Differentiated Adipocytes 6
(Date:7/24/2008)... Stanford, CASteroids bulk up plants just as they...signals that tell the genes to boost growth and de...han in human and animal cells. A new study by plan...merging molecular approach called proteomics to id...nderstanding how these plant hormones activate gen...
(Date:7/24/2008)... Glasses embedded with a telescope promise to mak...ve and do other activities requiring sharper dista...ists describe the advantages of these innovative g...d in the May/June issue of Journal of Biomedical ... month. , "This new design has several advantag...
(Date:7/24/2008)... July 24, 2008 A new study by researchers from C...th addresses one of the most challenging issues in...transmission in poor countries. In these settings...he best outcome for their infants, they should exc...four to six months after birth. But according to t...
(Date:7/24/2008)... Researchers at The Pennsylvania State University...iscovered that the efficacy of imiquimod, a clinic...t antiviral and antitumor activity, is dependent o...r) axis for its action. This discovery, reported ...d Medicine , provides new insights into a widely u...
Breaking Biology News(10 mins):Plant steroids offer new paradigm for how hormones work 2Plant steroids offer new paradigm for how hormones work 3Telescope embedded in glasses lens promises to make driving easier for visually impaired 2Telescope embedded in glasses lens promises to make driving easier for visually impaired 3Early cessation of breastfeeding by HIV+ women in poor countries and child survival 2Early cessation of breastfeeding by HIV+ women in poor countries and child survival 3Imiquimod, an immune response modifier, is dependent on the OGF-OGFr signaling pathway 2Clarient Names Michael J Pellini M D Chief Operating Officer 2845 1Clarient Names Michael J Pellini M D Chief Operating Officer 2845 2Clarient Names Michael J Pellini M D Chief Operating Officer 2845 3Clarient Names Michael J Pellini M D Chief Operating Officer 2845 4Safety Tips for a Fun and Spooky Halloween 2843 1Safety Tips for a Fun and Spooky Halloween 2843 2Prime Therapeutics Announces URAC Accreditation 2840 1Prime Therapeutics Announces URAC Accreditation 2840 2National Domestic Violence Hotline Unveils 10 Year Blueprint to Significantly Reduce Domestic Violence in America 2835 1National Domestic Violence Hotline Unveils 10 Year Blueprint to Significantly Reduce Domestic Violence in America 2835 2National Domestic Violence Hotline Unveils 10 Year Blueprint to Significantly Reduce Domestic Violence in America 2835 3National Domestic Violence Hotline Unveils 10 Year Blueprint to Significantly Reduce Domestic Violence in America 2835 4
...e thought to be essential in helping chemotherapy ...In a new study of chemo patients, scientists at th...Cancer Institute found that 70 percent of subjects...till alive after five years. Patients with normal ... findings raise the possibility of a new strategy ...
...it comes to growing cells in a lab, technique matt... cells grown in three-dimensional cultures use 1,7... in standard two-dimensional petri dishes. , , T...ineering, adds to a growing body of research showi...t cell growth and function. This research shows th...
...te hundreds of families being told their children ...dren may be able to eat peanuts safely, a study by...(UNSW) and Sydney Children,s Hospital has found. ,...ording to the Australasian Society of Clinical Imm...ant finding," said Dr Brynn Wainstein, a Sydney Ch...
...eport, published in the prestigious international ...aecology, found that the rise could not be explain... such as complications in pregnancy or labour/deli..., The research project looked at all births in Wes...0,000 births) and analysed the mode of delivery....
Other Biology News:Gene thought to assist chemo may help cancer thrive 2Gene thought to assist chemo may help cancer thrive 3Growing nerve cells in 3-D dramatically affects gene expression 2Peanut allergies overstated, study finds 2Study shows dramatic increase in Caesarean sections 2
RAT ANTI MOUSE JAM-2 Immunogen: Recombinant soluble JAM-2
casein kinase 2, alpha 1 polypeptide, transcript variant 2, mRNA (cDNA clone MGC:15232 IMAGE:4121882), complete cds
...y RNA Spikes for the normalization and control of ...ng and for protocol assessment and optimization. C...ybridization stringency and background. Normalize ...Spots, and complementary RNA Spikes for the normal...
Kit for Detection of Mitochondrial Membrane Potential
Biology Products: